Product Overview

Supatret C Gel is a prescription topical medication that combines two well‑established anti‑acne agents, clindamycin and tretinoin, into a single gel formulation. Produced by Sun Pharmaceutical Industries Ltd, the product is packaged in a 15 g tube and is specifically indicated for the treatment of moderate to severe acne vulgaris in adults. The gel delivers a controlled amount of clindamycin, a topical antibiotic that reduces bacterial colonization, alongside tretinoin, a vitamin A derivative that normalizes keratinocyte turnover and prevents the formation of new comedones. This dual‑action approach addresses both the inflammatory and follicular components of acne, offering a comprehensive therapeutic option that can improve lesion counts, reduce erythema, and minimize the risk of post‑inflammatory hyperpigmentation. For additional clinical guidance, refer to the NIH acne management guidelines

What is Supatret C Gel

Supatret C Gel represents a fixed‑dose combination of clindamycin 1 % and tretinoin 0.025 % in a hydroalcoholic gel base. Clindamycin exerts its antibacterial effect by inhibiting protein synthesis in Propionibacterium acnes, thereby decreasing the inflammatory response associated with acne lesions. Tretinoin binds to nuclear retinoic acid receptors, promoting rapid differentiation of epidermal keratinocytes and preventing the obstruction of follicular openings. The synergistic interaction of these two agents provides a more rapid reduction in papular and pustular lesions than either component used alone, while the gel vehicle ensures good skin penetration and a non‑greasy feel. The formulation is intended for external use only and should be applied to clean, dry facial skin as directed by a qualified healthcare professional.

Uses and Benefits

Clinicians prescribe Supatret C Gel for the treatment of inflammatory acne lesions, including papules, pustules, and moderate nodular components. The primary benefits of this combination therapy stem from its ability to simultaneously target bacterial overgrowth and abnormal follicular keratinization. By reducing the population of acne‑causing bacteria, clindamycin diminishes inflammation, while tretinoin accelerates the shedding of dead skin cells, preventing the clogging of pores that leads to new lesion formation. Over a typical treatment course of eight to twelve weeks, patients often observe a noticeable decrease in the number and severity of inflammatory lesions, improved skin texture, and a lower incidence of hyperpigmented spots that can follow severe acne. Because the two actives work through distinct pathways, the combination can achieve synergistic efficacy without significantly increasing the risk of severe adverse events when used as prescribed.

• Targets bacterial colonization
• Reduces follicular hyperkeratosis
• Improves skin tone and texture
• Minimizes post‑inflammatory hyperpigmentation

How It Works

The mechanism of action of Supatret C Gel can be understood by examining each active ingredient separately and then considering their combined effect. Clindamycin penetrates the follicular epithelium and binds to the 50S ribosomal subunit of susceptible bacteria, halting protein synthesis and leading to bacterial death. This reduces the release of pro‑inflammatory mediators such as cytokines and chemokines that amplify acne lesions. Tretinoin, on the other hand, modulates gene expression in keratinocytes, promoting differentiation and inhibiting the overproduction of sebum‑trapping keratin plugs. The combined effect results in a dual reduction of both the microbial load and the comedonal component of acne, leading to a clearer complexion. Clinical studies have demonstrated that the combination yields higher complete clearance rates than monotherapy, especially when used consistently over a minimum of eight weeks.

Dosage Guidelines

Supatret C Gel should be applied as a thin layer to the entire affected area of the face once daily, preferably at nighttime after the skin has been cleansed and patted dry. A pea‑size amount is generally sufficient for the entire facial surface; using more than the recommended quantity does not enhance efficacy but may increase the likelihood of irritation. Before application, ensure that the skin is free of makeup, sunscreen, or other topical products, allowing the gel to make direct contact with the epidermis. After applying, allow the medication to absorb for at least 20–30 minutes before proceeding with any additional skincare products, such as moisturizers or sunscreens. If a dose is missed, the patient should apply the missed dose as soon as remembered, unless it is close to the time of the next scheduled application; in that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should avoid applying the gel to broken skin, mucous membranes, or near the eyes, and they should not use occlusive dressings or heavy cosmetics over the treated area without medical advice.

Side Effects

Most individuals using Supatret C Gel experience mild, transient skin reactions that typically resolve with continued use. The most commonly reported adverse events include erythema, peeling, a burning or stinging sensation, and dryness of the treated skin. These effects are generally dose‑dependent and may be mitigated by applying a non‑comedogenic moisturizer after the gel has fully absorbed. In rare cases, patients may develop contact dermatitis, secondary bacterial infection, or an allergic reaction characterized by swelling, itching, or rash. Should any of these more severe symptoms occur, the medication should be discontinued immediately, and a healthcare professional should be consulted. For a comprehensive overview of reported side effects, refer to the Drugs.com product monograph or the prescribing information approved by the U.S. Food and Drug Administration.

Warnings and Precautions

Supatret C Gel is intended for external use only and must be kept out of reach of children and pets. Patients with a known hypersensitivity to clindamycin, tretinoin, or any excipients in the formulation should avoid its use. Because tretinoin can increase photosensitivity, patients are advised to limit exposure to natural sunlight and artificial UV light, and to apply broad‑spectrum sunscreen with a minimum SPF of 30 during daylight hours. Concomitant use of other topical acne medications should be reviewed with a clinician to prevent excessive irritation. Pregnant or breastfeeding women should consult their physician before initiating therapy, as retinoids have the potential to be teratogenic. The product should be stored at room temperature, away from moisture and direct heat, and any expired medication should be discarded safely. For detailed safety information, see the MedlinePlus drug information portal

Frequently Asked Questions

Q: Can Supatret C Gel be used on areas of the body other than the face?

A: The gel is formulated for facial application; off‑label use on other body regions should only be performed under the supervision of a qualified healthcare provider.

Q: How long does it typically take to notice visible improvement?

A: Most patients observe a reduction in inflammatory lesions after four to six weeks of consistent nightly application, though individual response times can vary based on acne severity and skin type.

Q: Is it safe to apply sunscreen over the gel?

A: Yes; daily use of a broad‑spectrum sunscreen is recommended because tretinoin can increase skin sensitivity to ultraviolet light, and sun protection helps prevent irritation and hyperpigmentation.

Q: Can I use a moisturizer or other skincare products alongside Supatret C Gel?

A: After the gel has fully absorbed—usually after 20–30 minutes—patients may apply a non‑comedogenic moisturizer or other gentle skincare products, ensuring they do not interfere with the medication’s efficacy.

Q: Does Supatret C Gel cause systemic side effects such as weight gain?

A: Systemic absorption of the active ingredients is minimal; however, any new or unexplained symptoms should be reported to a healthcare professional for further evaluation.

Related Products

• Vortidif 20 Mg (Vortioxetine)
• Vortidif 5 Mg (Vortioxetine)
• Pramipex 0.25 mg (Pramipexole)
• Mirtaz 30 Mg (Mirtazapine)
• Lurasidone 40 mg (Generic)
• Ropinirole 1 mg (Generic)
• Adesam 200 mg (Ademetionine/S-Adenosyl Methionine)
• Suminat 25 mg (Sumatriptan)
• Syncapone 100 mg (Levodopa/Carbidopa/Entacapone)
• Cyclomune Eye Drop (Cyclosporin)
• Glypride 4 mg (Glimepiride)
• Natrise 15 mg (Tolvaptan)